CrushSCI.com
103.6Average days
63Median days
28Fastest days
301Longest days
1652025 publications

Paper Review Records

All Paper Review Records

19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

55 days

Hydrogel-based drug delivery systems for oral mucositis: a systematic review of preclinical models and translational perspectives

Authors
Claudia Carrara Cotomacio; Caio Camargo Calarga; João Pedro Alves Noronha de Abreu; Alyne SimõesShow moreShow less
Affiliations
1. University of São Paulo; 2. Paulista University (UNIP); 3. Pediatric Oncology Institute/GRAACC (Support Group for Children and Adolescents with Cancer)Show moreShow less
Source PDF DOI Publisher page
41 days

Beyond bioequivalence: a critical overview of the innovator AmBisome as the reference standard for liposomal amphotericin B generics

Authors
Francelise Bridi Cavassin; Marcello Mihailenko Chaves MagriShow moreShow less
Affiliations
1. Faculdades Pequeno Príncipe (FPP); 2. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFAMUSP)Show moreShow less
Source PDF DOI Publisher page
134 days

Current trends in semaglutide therapy and strategies to improve its bioavailability

Authors
Swasthik Nayak; Akanksha D. Dessai; Usha Y. NayakShow moreShow less
Affiliations
1. Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher EducationShow moreShow less
Source PDF DOI Publisher page
54 days

Predicting clinical efficacy of lung gene delivery in people with cystic fibrosis: which in vitro and in vivo models best predict outcomes in human lungs?

Authors
Miftakul Munir; Jeremy Wiyana; Rhiannon B. Werder; Neville J. Butcher; Rachel Burow; Alexandra McCarron; Qichen Yu; Shafagh A. Waters; Lisa M. KaminskasShow moreShow less
Affiliations
1. University of Queensland; 2. The Royal Children’s Hospital; 3. reNEW Melbourne; 4. University of Melbourne; 5. Adelaide University; 6. Women’s and Children’s Hospital; 7. UNSW Sydney; 8. Sydney Children’s HospitalShow moreShow less
Source PDF DOI Publisher page
43 days

Bioconjugates for breast cancer theranostics: improving target selectivity and treatment efficacy

Authors
Neha Jain; Shreya Kaul; Rupali Verma; Aruna Sharma; Manisha Pandey; Amit Chaudhary; Upendra NagaichShow moreShow less
Affiliations
1. Amity University; 2. Chitkara University; 3. Central University of Haryana; 4. Saveetha Institute of Medical and Technical ScienceShow moreShow less
Source PDF DOI Publisher page
79 days

Biomarker-driven and AI-assisted nanomedicine for breast cancer: advancing precision drug delivery from bench to bedside

Authors
Jaleh Barar; Rais Ansari; Yadollah OmidiShow moreShow less
Affiliations
1. Nova Southeastern UniversityShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.